Suzhou Jiecheng Medical Technology Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Suzhou Jiecheng Medical Technology Co., Ltd. - overview

Established

2009

Location

Suzhou, Jiangsu, China

Primary Industry

Medical Devices & Equipment

About

Established in 2009 and based in Suzhou, China, Suzhou Jiecheng Medical Technology Co. , Ltd. is a healthcare company that focuses on development, production and sale of artificial heart valves and implants. As of 2022, the company has over 200 international patents and patent applications.


The company established the TMVR-VIV mitral valve-in-valve clinical research centre in 2020 and the bio nano park R&D and production site in Suzhou industrial park in 2018. The company's main business is development, production and sale of artificial heart valves and implants. The company self-developed J-Valve® TA transapical interventional heart valve replacement system and J-Valve® TF transvascular interventional bioprosthetic heart valve replacement system.


Current Investors

Genesis Medtech, 6 Dimensions Capital

Primary Industry

Medical Devices & Equipment

Sub Industries

Surgical Devices

Website

www.jiechengmedical.com

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Suzhou Jiecheng Medical Technology Co., Ltd. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSuzhou Jiecheng Medical Technology Co., Ltd.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.